BERKELEY'S NEWS • MARCH 27, 2023
CRISPR-Cas9
Page 5 of 5
Campus
SEPTEMBER 24, 2015
Jennifer Doudna named citation laureate for development of gene-editing method
The Intellectual Property and Science division of Thomson Reuters has named UC Berkeley chemistry and molecular and cell biology professor Jennifer Doudna as a citation laureate for her development of the CRISPR-Cas9 genome-editing method.
Campus
SEPTEMBER 24, 2015
Jennifer Doudna named citation laureate for development of gene-editing method
The Intellectual Property and Science division of Thomson Reuters has named UC Berkeley chemistry and molecular and cell biology professor Jennifer Doudna as a citation laureate for her development of the CRISPR-Cas9 genome-editing method.
Research & Ideas
MAY 12, 2015
UC Berkeley, MIT scientists argue over patent rights to gene-editing tool
Disagreement persists between scientists at UC Berkeley and the Massachusetts Institute of Technology over the disputed patent rights to a gene-editing technology known as CRISPR-Cas9 potentially worth billions of dollars.
Research & Ideas
MAY 12, 2015
UC Berkeley, MIT scientists argue over patent rights to gene-editing tool
Disagreement persists between scientists at UC Berkeley and the Massachusetts Institute of Technology over the disputed patent rights to a gene-editing technology known as CRISPR-Cas9 potentially worth billions of dollars.
Research & Ideas
APRIL 01, 2015
Researchers advocate open discourse on genome editing
On March 19, researchers led by campus professor of chemistry and molecular and cell biology Jennifer Doudna published an article in an online version of the journal Science advocating open discourse regarding the use of technology that can manipulate the human genome.
Research & Ideas
APRIL 01, 2015
Researchers advocate open discourse on genome editing
On March 19, researchers led by campus professor of chemistry and molecular and cell biology Jennifer Doudna published an article in an online version of the journal Science advocating open discourse regarding the use of technology that can manipulate the human genome.
